Announcement.

MASTER PHARM SA (17/2017) Estimated financial results of Master Pharm S.A. for three quarters of 2017

The MASTER PHARM SA Management Board ("Issuer") makes public the estimated financial results of the Master Pharm SA Capital Group. ("Group") and the Issuer, for three quarters of 2017, ie 01/01/2017 to 31/09/2017. - Consolidated estimated sales revenues of the Group after three quarters of 2017 amounted to PLN 41.00 million compared to 32.50 PLN million in the same period of 2016, which is an increase of PLN 8.50 million - ie by 26% y / y. - The consolidated estimated gross result on sales of the Group after three quarters of 2017 was PLN 4.90 million compared to PLN 07 million in the corresponding period of 2016, which is a decrease by PLN 1.17 million - ie by 19% yoy. - Consolidated estimated net result of the Group after three quarters of 2017 amounted to PLN 3.80 million against 4 PLN 66 million in the corresponding period of 2016, which is a decrease by PLN 0.86 million - ie approx. 18% yoy. - Unit estimated sales revenues of Master Pharm SA after three quarters of 2017, it amounted to PLN 32.60 million compared to PLN 26.73 million in the corresponding period of 2016, which is an increase of PLN 5.87 million - ie by 22% y / y. - Unitary estimated profit before tax sales of Master Pharm SA after three quarters of 2017, it amounted to PLN 4.34 million compared to PLN 4.42 million in the corresponding period, which is a decrease by PLN 0.08 million - ie by 2% yoy. - Unit estimated net result of Master Pharm S.A. after three quarters of 2017, it amounted to PLN 3.49 million compared to PLN 3.77 million in the corresponding period, which is a decrease by PLN 0.28 million - ie 7% yoy. Despite the recorded increase in revenues both at the level of the Issuer and the entire Capital Group, the Group's financial result remains under pressure of costs which at the consolidated level after three quarters of 2017 amounted to PLN 36.09 million and in the corresponding period of 2016 amounted to PLN 26.18 million PLN, which means an increase by PLN 9.91 million, ie 38% y / y. The costs of energy, raw materials and materials increased significantly, ie by 56% y / y, which was influenced, apart from the increase in production volume, by one-off events related to production. In addition, there was an increase in wages by 39% yoy, which is the result of employment of new employees to the greatest extent. Depreciation charges increased by 60% yoy, costs of external services grew by 16%. The above financial results are estimates obtained in the preparation of the financial statements, the results published in the report in the first three quarters of 2017 may be limitedvary from the above figures.

Source: company website, investor relations, current and periodic reports.

ALL COMPANY ANNOUNCMENTS
Company information
Company name:Master Pharm SA
ISIN:PLMSTPH00016
NIP:9512060837
Adress: ul. Wersalska 8 91-203 Łódź
Phone:+48 42 7126200
website:www.masterpharm.pl

Copyright © 2017 PolandStockExchange
This website uses cookies (Regulations / Cookie Policy).